Armistice Capital »

Mural Oncology shares owned by Armistice Capital

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.1M 1.7M 4.89

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Mural Oncology

Armistice Capital
Westfield Capital Management Company
BlackRock
Vanguard Group
Verition Fund Management
Solas Capital Management
Alta Fundamental Advisers
Newtyn Management
Prosight Management
Geode Capital Management
PRIMECAP Management Company
Baker Bros. Advisors
Sonic GP
Nuveen Asset Management
Squarepoint Ops

View all funds holding Mural Oncology